LIFECODES胎儿生长研究中大于胎龄儿出生者的胎儿生长轨迹
该研究在LIFECODES胎儿生长研究中对235例大于胎龄儿出生者的孕中晚期超声测量数据进行基于组的多轨迹建模,识别出追赶生长、腹围与股骨长比例性生长、腹围与股骨长不成比例生长及持续偏大4种胎儿生长轨迹,不同轨迹与不同的妊娠特征及不良出生结局分布相关。
要点
- 大于胎龄儿出生者可识别出4种不同的胎儿生长轨迹。
- 追赶生长轨迹组孕前糖尿病比例更高(36% vs 10%-17%),血糖控制正常比例更低(40% vs 65%-75%)。
- 追赶生长轨迹组巨大儿(86% vs 67%-73%)和新生儿重症监护病房入住(32% vs 14%-21%)比例更高。
核心结论
- 大于胎龄儿出生者的胎儿生长轨迹与不同妊娠特征及不良出生结局分布相关;追赶生长表型可能独特地与孕前糖尿病暴露及更高的新生儿重症监护病房入住风险相关;不良结局风险在大于胎龄儿中可能并非均匀分布。
研究设计与样本
- 研究为LIFECODES胎儿生长研究中235例大于胎龄儿出生者的轨迹识别与描述性分析,从健康记录中提取孕中晚期胎儿生长超声测量,对头围、腹围和股骨长z评分应用基于组的多轨迹建模识别多变量胎儿生长轨迹,并汇总不同轨迹成员的社会人口学变量、妊娠特征和出生结局。
主要发现
- 研究识别出4种大于胎龄儿胎儿生长轨迹:追赶生长(n=28)、腹围与股骨长比例性生长(n=67)、腹围与股骨长不成比例生长(n=96)和持续偏大(n=44)。
- 追赶生长组胎儿孕中期相对体型小(即头围、腹围和股骨长z评分低于平均水平),孕晚期相对体型大,生长由腹围和头围相对尺寸增加驱动。
- 追赶生长组分娩者血糖控制正常比例更低(40% vs 其他大于胎龄儿亚组65%-75%),孕前糖尿病比例更高(36% vs 10%-17%)。
- 追赶生长组婴儿巨大儿比例更高(86% vs 其他大于胎龄儿亚组67%-73%),新生儿重症监护病房入住比例更高(32% vs 14%-21%)。
- 持续偏大组胎儿整个孕期所有生长参数相对尺寸最大,不良出生结局风险低于其他大于胎龄儿亚组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出部分轨迹内个体数量少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Babies born large-for-gestational age have an increased risk of adverse health outcomes, including birth injuries, childhood obesity, and cardiometabolic disorders. However, little work has been done to characterize patterns of fetal growth among large-for-gestational age births, which may further elucidate high- and low-risk subgroups. OBJECTIVE: This study aimed to identify subgroups of large-for-gestational age births based on trajectories of fetal growth derived from prenatal ultrasound measurements and explore differences in sociodemographic, pregnancy, and birth outcome characteristics across subgroups. STUDY DESIGN: This study identified and described trajectories of fetal growth among large-for-gestational age births (n=235) in the LIFECODES Fetal Growth Study. Ultrasound measurements of fetal growth in middle to late pregnancy were abstracted from health records. Group-based multi-trajectory modeling was applied to measurements of head circumference, abdominal circumference, and femur length z-scores to identify multivariate trajectories of fetal growth. Moreover, sociodemographic variables, pregnancy characteristics, and birth outcomes based on trajectory membership were summarized. RESULTS: This study identified 4 multivariate trajectories of fetal growth among large-for-gestational age births: catch-up growth (n=28), proportional abdominal circumference-to-femur length growth (n=67), disproportional abdominal circumference-to-femur length growth (n=96), and consistently large (n=44). Fetuses in the "catch-up growth" group exhibited small relative sizes in midpregnancy (ie, below average head circumference, abdominal circumference, and femur length z-scores) and large relative sizes in late pregnancy. Growth among these births was driven by increases in relative abdominal circumference and head circumference sizes. Participants who delivered births assigned to this group were less likely to have normal glucose control (40% vs 65%-75%) and more likely to have pregestational diabetes mellitus (36% vs 10%-17%) than other large-for-gestational age subgroups. In addition, the babies in this trajectory group were more likely to have macrosomia (86% vs 67%-73%) and to be admitted to the neonatal intensive care unit (32% vs 14%-21%) than other large-for-gestational age subgroups. In contrast, babies in the "consistently large" group had the largest relative size for all growth parameters throughout gestation and experienced a lower risk of adverse birth outcomes than other large-for-gestational age subgroups. CONCLUSION: This study characterized several trajectories of fetal growth among large-for-gestational age births, which were related to different pregnancy characteristics and the distribution of adverse birth outcomes. Although the number of individuals within some trajectories was small, a subgroup that exhibited a catch-up growth phenotype during gestation was identified, which may be uniquely associated with exposure to pregestational diabetes mellitus and a higher risk of admission to the neonatal intensive care unit. These results have highlighted that the risk of adverse outcomes may not be evenly distributed across all large-for-gestational age births.
引用
- Bommarito PA, Cantonwine DE, Stevens DR, et al. Fetal growth trajectories of babies born large-for-gestational age in the LIFECODES Fetal Growth Study. Am J Obstet Gynecol. 2022. PMID: 36241081. doi:10.1016/j.ajog.2022.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。